461: Ingrained Invader Inhibits Infectors
vor 4 Jahren
This episode: Training a phage strain on bacteria can increase its
ability to control those bacteria for much longer than an untrained
phage! (5.7 MB, 8.3 minutes) Show notes: Microbe of the
episode: Pepper yellow leaf curl Indonesia virus...
Podcast
Podcaster
Beschreibung
vor 4 Jahren
This episode: Training a phage strain on bacteria can increase
its ability to control those bacteria for much longer than an
untrained phage!
Download Episode (5.7 MB, 8.3 minutes)
Show notes:
Microbe of the episode: Pepper yellow leaf curl Indonesia virus
News item
Takeaways
With resistance to antibiotics spreading more and more
among deadly bacteria, finding alternatives to treat
infections is becoming more important. One option is
phage therapy, using viruses that infect bacteria to
weaken or wipe out pathogens, but this can be tricky.
Sometimes it takes too long to prepare an effective
population of phage for treatment, and sometimes the
target pathogen evolves resistance to the phage too
quickly
In this study, a phage that was trained, or pre-evolved,
to infect specific bacteria more effectively, was able to
dominate the population consistently and prevent it from
becoming fully resistant. For comparison, against an
untrained strain of the same phage, the bacteria
developed almost complete resistance after several days.
Journal Paper:
Borin JM, Avrani S, Barrick JE, Petrie KL, Meyer JR. 2021.
Coevolutionary phage training leads to greater bacterial
suppression and delays the evolution of phage resistance.
Proc Natl Acad Sci 118.
Other interesting stories:
Engineered gut bacteria could sense and indicate bowel
inflammation
Email questions or comments to bacteriofiles at gmail dot
com. Thanks for listening!
Subscribe: Apple Podcasts, Google Podcasts, Android, or RSS.
Support the show at Patreon, or check out the show
at Twitter or Facebook.
Weitere Episoden
9 Minuten
vor 2 Jahren
11 Minuten
vor 2 Jahren
9 Minuten
vor 2 Jahren
11 Minuten
vor 2 Jahren
12 Minuten
vor 2 Jahren
Kommentare (0)
Melde Dich an, um einen Kommentar zu schreiben.